Search

everythinglearnresearchcommunity

for

Search:↓

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

The Consciousness Energy Healing Treatment significantly increased human dermal papilla cell growth, suggesting it may help with hair growth and skin disorders.

Certain cells from hair follicles can create new hair and contribute to hair growth when implanted in mice.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Vitiligo treatments are improving but relapses are common.

VEGF and minoxidil affect hair growth by altering eicosanoid production in hair cells.

Minoxidil boosts growth factor in hair cells, potentially promoting hair growth.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Exosomes from dermal papilla cells help hair follicle stem cells grow and survive.

Muscarinic acetylcholine receptors in skin cells help regulate and promote hair growth.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

Malva verticillata seed extracts, specifically linoleic acid, can help reduce hair loss and promote hair growth by activating certain cell signals.

Malva verticillata seed extracts, specifically linoleic acid, can help reduce hair loss and promote hair growth by activating a specific pathway in hair cells.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

Combining specific inducers helps dermal papilla cells regain hair-forming ability.

Biomimetic dermal papilla spheres can help regenerate hair to some extent.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Two microRNAs in stem cell exosomes help treat hair loss by targeting a specific signaling pathway.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Ageing and increased senescent cells significantly contribute to common hair loss.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Topical immunotherapy is the best treatment for severe alopecia areata.